of the single nucleotide polymorphism (SNP)-SNP interaction model can facilitate the analysis of the susceptibility to disease. The model explains the risk of association between the genotypes and the disease in case-control study. Thus, many mathematic methods are widely applied to identify the statistically significant model such as odds ratio (OR), chi-square test, and error rate. However, a huge number of data sets have been found to limit the statistical methods to identify the significant model. In this study, we propose a novel statistical method, complementary-logic particle swarm optimization (CLPSO), to increase the efficiency of significant model identification in case-control study. The complementary-logic is implemented to improve the PSO search ability and identify a better SNP-SNP interaction model. Six important breast cancer genes including 23 SNPs and simulated huge number of data sets were selected as the test data sets. The methods of PSO and CLPSO were applied on the identification of SNP-SNP interactions in the two-way to five-way. In results, the OR evaluates the breast cancer risk of the identified SNP-SNP interaction model. Compared to the corresponding non-interaction model, if the OR value is greater than 1 that indicates the model is significant risk between cases and controls. The results showed that CLPSO is able to identify the significant models for specific SNP-SNP interaction of two-way to five-way (OR value: 1.153-1.391; confidence interval (CI): 1.05-1.79; p-value: 0.01-0.003). The model suggests that the genes ESR1, PGR, and SHBG may be an important role in the interactive effects to breast cancer. In addition, we compared the search abilities of PSO and CLPSO for identification of the significant model. Results revealed that CLPSO can identify better model with difference values between cases and controls than PSO; it suggests CLPSO can be used to identify a better SNP-SNP interaction models.
I. INTRODUCTION
SNP is an common bio-marker in genomes, and it has widely used in the investigation of association analysis of diseases [1] , cancers [2] , and pharmacogenomics [3] . These analyses reported that SNPs have specific associations with the risk of certain diseases. However, most of the SNP analyses were focused on a single SNP. The low or marginal significant SNPs could be excluded, but these SNPs may have significant associations with disease when they are combined as SNP-SNP interaction model. Thus, the identification of appropriate interaction model is an important issue for SNP analysis.
A SNP-SNP interaction model includes the SNPs and their corresponding genotypes (AA, Aa, and aa). Therefore, the possible models are rapidly increased by the number of SNPs and their corresponding genotypes. The huge potential SNP-SNP interaction model makes the statistical method difficultly identify the significant models. Currently, machine learning have applied to help statistical method on the identification of appropriate interaction models, such as particle swarm optimization (PSO) [4] - [6] and genetic algorithm (GA) [7] , [8] . PSO and GA have the properties of randomized search and are an optimization technique that derives its working principles from simulations of the organism behavior. They provide a fast identification in high-dimension problem, e.g., biomarker selection [9] . Thus, they can be employed to identify an optimal SNP combination from the huge possible combinations. Although they had overcome the excessive computational time to identify the significant models, the search ability remains a challenge. Thus, an improved method is required to explore the SNP-SNP interaction.
Here, we propose a complementary-logic PSO, named CLPSO, to identify the significant model associated with SNP-SNP interactions. In this study, we hypothesize that the interactions between polymorphisms of genes may have a synergistic or non-additive effect on the pathogenesis of a disease. This interaction may explain differences between cases and controls in the disease risk. Six breast cancer related genes (COMT, CYP19A1, ESR1, PGR, SHBG, and STS) including 23 SNPs were selected to simulate huge number of data sets. Results indicate that CLPSO can identify the appropriate interaction models in breast cancer from the huge number of simulated data sets, and the results provide the significant information for determining the SNP-SNP interaction model with maximal difference between the cases and controls.
II. METHODS

A. Problem Definition
For SNP-SNP interaction problem, a vector like X = [x 1 , x 2 , x 3 , ..., x D ] is represented as one condition and the solution for each parameter x i is a real number; in this study the SNP-SNP interaction models are refereed as the different SNP combinations with their corresponding genotypes. The object of SNP-SNP interaction model is a search for the vector X * , which maximizes an objective function f (X)(f : δ  R D →R), i.e., f (X * ) > f (X) for all X ∈ δ, where δ is a non-empty large finite set serving as the search space, and δ = R D . The objective function defined the difference between frequencies of case group and control group, which are according to vector X, i.e., f(X) = () is generally complicated by the existence of non-linear objective functions with multiple local optima. A local optima f l = f (X l ) in this study defined as ε >
, where ||.|| indicates any p-norm distance measure. The flexibilities of given constraints and vector space in problem influence the finding best-suited solution in PSO process. We aim at finding a set of SNP combinations with their genotypes for which the overall performance of the model will be the best under some given conditions.
B. Particle Swarm Optimization
PSO is based on a population stochastic optimization technique; it simulates the social behavior of organisms as birds in a flock or fish in a school. Each individual (named bird or particle) uses its own memory and common knowledge gained by the entire swarm to find an optimal position. The particles have two important properties: (1) a fitness value, which is determined by objective function, and (2) a velocity, which affects the movement of the particle. During the generation, each particle moves its position according to its own experience and the common experience of all particles. Finally, the particles follow the current best particle in the search space until a predefined number of iterations are reached. The flowchart of the method is shown in Fig. 1 .
Initialize position X, associated velocities V, pbest and gbest of the population, set G = 0. 
C. Complementary-Logic Particle Swarm Optimization (CLPSO)
The complementary-logic aims to avoid the particles to be easily trapped in a local optimum by moving their position to a new region in the problem space. In traditional PSO, particles could be trapped in a local optimum due to the premature convergence of population. All particles are randomly generated in the problem space and updated by the pbest, which is the best fitness value in the particle itself has achieved so far, and gbest, which is the best fitness of all particles in the population so far. However, all particles based on update function can moves toward the gbest and the distance between gbest and the neighboring particles can be gradual decreased by increased generation. Here, we use complementary-logic to improve the PSO search ability for SNP-SNP interaction model, in which the complementary particles are introduced to avoid premature convergence. These complementary particles replace 50% of the randomly selected particles in the population. The procedure of CLPSO includes (1) initialization of the parameter vectors, (2) objective function, (3) identification of pbest and gbest, (4) particle updating, (5) complementary-logic adaption of particles, and (6) judgment of termination condition.
D. Initialization of the Parameter Vectors
CLPSO searches for a global optimum point in a D-dimensional real parameter space R D . It begins with a randomly initiated population of NP D dimensional real-valued parameter vectors. Each vector, also known as genome/chromosome, forms a candidate solution to the multidimensional optimization problem. We shall denote subsequent generations in CLPSO by G = 0, 1, ..., G max . Since the parameter vectors are likely to be changed over different generations, we may adopt the following notation for representing the i th vector of the population at the current generation:
For each parameter of the problem, there may be a certain range within which the value of the parameter should be restricted, often because parameters are related to physical components or measures that have natural bounds (for example if one parameter is a length or mass, it cannot be negative). The initial population (at G = 0) should cover this range as much as possible by uniformly randomizing individuals within the search space constrained by the prescribed minimum and maximum bounds: X min = {x 1,min , x 2,min , …, x D,min } and X max = {x 1,max , x 2,max , …, x D,max }. Therefore, we may initialize the j th component of the i th vector as:
where rand i,j 3, 1, 3 ), and can be described by the SNPs associated with the genotypes as follows: (2, 3), (4, 1) and (6, 3).
E. Objective Function
In the CLPSO process, the fitness function value measures the quality of chromosomes. The SNP-SNP interaction study focuses on the particular SNP combinations to detect the highest fitness value, i.e., the maximum difference value between breast cancer cases and non-cancer cases. This criterion divides the fitness function into three separate steps, and the relevant equation can be written as:
The concept of the designed fitness value uses the intersection of set theory to evaluate the difference value between breast cancer cases and non-cancer cases. The intersection of two sets is the set that contains all elements found in both sets, but no other elements. For example: X = (SNP 2,3 , Genotype 3,2 ) is used to evaluate the number of matching conditions in the breast cancer cases and non-cancer cases. Let's suppose the number of independent matching SNP 2 with genotype 3 and SNP 3 with genotype 2 is 273 in the breast cancer cases, and the number of independent matching SNP 2 with genotype 3 and SNP 3 with genotype 2 is 51 in the non-cancer cases. According to Eq. (6), the fitness value is determined by subtracting 51 from 273, leaving 222, which represents a high risk.
F. Identification of pbest and gbest
In CLPSO, each particle can find the currently best position and velocity (pbest) and the global best position and velocity (gbest) when population moving. If the fitness value of a particle P i in the current generation is better than the fitness value of pbest in the previous generation, then pbest is replaced by P i . If the fitness value of a particle P i in the current generation is better than gbest in the previous generation, gbest is also replaced by P i . Thus, each particle can adjust its position based on pbest and gbest in the next iteration.
G. Particle Updating
Each particle moves its position by updating the velocity in the next generation via an evaluation of pbest and gbest. The update functions of velocity and position are formulated in Eqs. (7) to (9) In Eq. (7), w max set to be 0.9, w min set to be 0.4 and Iteration max is the maximum generation number. In Eq. (8), r 1 and r 2 are random values between (0, 1); c 1 and c 2 are acceleration coefficients equal to 2; these coefficients constantly influence a particle moves in a single generation.
H. Complementary-Logic Adaption of Particles
The complementary-logic aims to avoid the particles are trapped into a local optimum by adjusting particles to a new region in the problem space. Thus, complementary-logic can facilitate the ensuring global exploration. The position of a trapped particle is changed by the Eq. (10). 
I. Judgment of Termination Condition
The CLPSO procedure is terminated if the maximum number of generation is reached. When the termination condition is reached, gbest is the optimal solution, i.e., best SNP-SNP interaction model. The maximum number of generation is explained in the parameter settings section.
J. Parameter Settings
We set the population size of parameters = 50, number of generations = 100. The termination condition is that the generations met the maximum number of allowed generations.
K. Statistical Analysis
Odds ratio (OR) is used to evaluate the difference between cases and controls. It determines the combination of genotypes and quantitatively measures the association disease risk [10] , and OR is defined as follows:
FN FP TN TP
   ratio Odds (11) where TP is the number of true positives, TN is the number of true negatives, FN is the number of false negatives and FP is the number of false positives. 
B. Analysis of Breast Cancer Susceptibility from 23 SNPS in Six Genes
The odds ratio and its 95% CI for all SNPs of six genes (COMT, CYP19A1, ESR1, PGR, SHBG, and STS) show that 13 SNPs , including COMT-rs6269, ESR1-rs3020314, ESR1-rs2175898, ESR1-rs1709182, ESR1-rs9478249, ESR1-rs1514348, ESR1-rs532010, PGR-rs660149, PGR-rs500760, SHBG-rs858518, SHBG-rs272428, SHBG-rs858524, and STS-rs2017591, display the statistically significant OR (p < 0.05) for breast cancer; the OR values range between1.268 to 0.846. Table II shows the results of SNP-SNP interaction models by 2 to 5-way. The left side in Table II represents the two to five SNP combinations. In these combinations, the 2-way model with SNP combinations and corresponding genotype indicates the rs3020314-Aa associated with rs660149-AA. The difference column indicates the difference between the cases and controls. For example, the 3-way model of CLPSO shows a difference value of 93 between cases and controls (602 vs. 509). Thus, the other models of PSO and CLPSO are explained as above mention. In CLPSO, the difference values between cases and controls are reduced from 126 to 41 in the two-way to five-way SNP-SNP interaction models. In PSO, the difference values between cases and controls are reduced from 126 to 15 in the two-way to five-way SNP-SNP interaction models. The larger difference value between cases and controls represents the better model. Table II shows the best interaction model in the 2-way to 5-way SNP-SNP interaction models. These results reveal that the total number of cases exceeds the total number of controls; it means that all models are a risk association in breast cancer. The right side in Table II shows the evaluated effects using odds ratio, 95% CI, and p-value. In PSO, the OR values in 2-way to 5-way SNP-SNP interaction models show the range of 1.109 to 1.459, and the 95% CI of OR is in the range of 0.89 to 2.28. Only the 2-way SNP-SNP interaction model shows the statistically significant (p-value < 0.05). However, in CLPSO, the OR values in 2-way to 5-way SNP-SNP interaction models show the range of 1.153 to 1.391 and the 95% CI of OR is in the range of 1.05 to 1.79. All of the SNP-SNP interaction models (2-way to 5-way) show significant OR values (p-value < 0.050).
C. Analysis of SNP-SNP Interaction Model with Difference between the Cases And Controls
D. Estimation of the Best Interaction Model Generated by PSO and CLPSO Using or and 95% CI in Breast Cancer
E. Comparison of PSO and CLPSO for the Interaction Model of Breast Cancer
The results represent the SNP-SNP interaction model identified by CLPSO has a better p-value than the model identified by PSO. PSO seems to provide a better OR value in the four-way SNP-SNP interaction model, however, the p-value shows the model does not statistically significant for breast cancer. The computational complexity of CLPSO is evaluated by objective function computation. Let n generation is implemented in a test, the computational complexity of PSO is O(n) which is the big-O in complexity analysis. The complementary-logic only adds an updated function, i.e., equation 10 . Thus, the computational complexity between PSO and CLPSO is the same, but CLPSO is superior to PSO in terms of identifying the best SNP-SNP interaction model.
IV. CONCLUSION
In this study, a novel method, CLPSO, is proposed to identify the statistically significant SNP-SNP interaction models between related genes of breast cancer. These models can be used to analyze disease susceptibility and provide the information of SNPs located in the genes and their associated pathways. We used the huge number of simulated data to test the methods of PSO and CLPSO, the results indicate CLPSO can robust to search the statistically significant models with the difference value between SNPs of genes amongst the huge number of SNPs involved in real data sets.
